Alkaline 0 8 0 8 B-clinical_variable
phosphatase 9 20 9 20 I-clinical_variable
< 21 22 21 22 O
2.5 23 26 23 26 B-upper_bound
upper 27 32 27 32 I-upper_bound
limit 33 38 33 38 I-upper_bound
of 39 41 39 41 I-upper_bound
normal 42 48 42 48 I-upper_bound
( 49 50 49 50 I-upper_bound
ULN 50 53 50 53 I-upper_bound
) 53 54 53 54 I-upper_bound
( 55 56 55 56 O
< 56 57 56 57 O
10 58 60 58 60 B-upper_bound
x 61 62 61 62 I-upper_bound
ULN 63 66 63 66 I-upper_bound
in 67 69 67 69 O
presence 70 78 70 78 O
of 79 81 79 81 O
bone 82 86 82 86 B-cancer
metastases 87 97 87 97 I-cancer
) 97 98 97 98 O

Aspartate 0 9 99 108 B-clinical_variable
aminotransferase 10 26 109 125 I-clinical_variable
( 27 28 126 127 I-clinical_variable
AST 28 31 127 130 I-clinical_variable
) 31 32 130 131 I-clinical_variable
< 33 34 132 133 O
5.0 35 38 134 137 B-upper_bound
x 39 40 138 139 I-upper_bound
normal 41 47 140 146 I-upper_bound
institutional 48 61 147 160 I-upper_bound
limits 62 68 161 167 I-upper_bound

Bilirubin 0 9 168 177 B-clinical_variable
( 10 11 178 179 I-clinical_variable
total 11 16 179 184 I-clinical_variable
) 16 17 184 185 I-clinical_variable
< 18 19 186 187 O
2.0 20 23 188 191 B-upper_bound
ml 24 26 192 194 I-upper_bound
/ 26 27 194 195 I-upper_bound
dl 27 29 195 197 I-upper_bound

Creatinine 0 10 198 208 B-clinical_variable
< 11 12 209 210 O
1.5 13 16 211 214 B-upper_bound
mg 17 19 215 217 I-upper_bound
/ 19 20 217 218 I-upper_bound
dl 20 22 218 220 I-upper_bound

Current 0 7 221 228 O
treatment 8 17 229 238 B-treatment
on 18 20 239 241 O
another 21 28 242 249 O
clinical 29 37 250 258 O
trial 38 43 259 264 O

Eastern 0 7 265 272 B-clinical_variable
Cooperative 8 19 273 284 I-clinical_variable
Oncology 20 28 285 293 I-clinical_variable
Group 29 34 294 299 I-clinical_variable
( 35 36 300 301 I-clinical_variable
ECOG 36 40 301 305 I-clinical_variable
) 40 41 305 306 I-clinical_variable
performance 42 53 307 318 I-clinical_variable
status 54 60 319 325 I-clinical_variable
0 61 62 326 327 B-lower_bound
- 62 63 327 328 O
1 63 64 328 329 B-upper_bound

Hemoglobin 0 10 330 340 B-clinical_variable
( 11 12 341 342 I-clinical_variable
Hgb 12 15 342 345 I-clinical_variable
) 15 16 345 346 I-clinical_variable
≥ 17 18 347 348 O
10.0 19 23 349 353 B-lower_bound
gm 24 26 354 356 I-lower_bound
/ 26 27 356 357 I-lower_bound
dl 27 29 357 359 I-lower_bound

Histologically 0 14 360 374 O
confirmed 15 24 375 384 O
breast 25 31 385 391 B-cancer
cancer 32 38 392 398 I-cancer

International 0 13 399 412 B-clinical_variable
normalized 14 24 413 423 I-clinical_variable
ratio 25 30 424 429 I-clinical_variable
( 31 32 430 431 I-clinical_variable
INR 32 35 431 434 I-clinical_variable
) 35 36 434 435 I-clinical_variable
< 37 38 436 437 O
1.5 39 42 438 441 B-upper_bound
, 42 43 441 442 O
except 44 50 443 449 O
for 51 54 450 453 O
subjects 55 63 454 462 O
receiving 64 73 463 472 O
warfarin 74 82 473 481 B-treatment
therapy 83 90 482 489 I-treatment

Known 0 5 490 495 O
human 6 11 496 501 B-chronic_disease
immunodeficiency 12 28 502 518 I-chronic_disease
virus 29 34 519 524 I-chronic_disease
( 35 36 525 526 I-chronic_disease
HIV 36 39 526 529 I-chronic_disease
) 39 40 529 530 I-chronic_disease
or 41 43 531 533 O
acquired 44 52 534 542 B-chronic_disease
immunodeficiency 53 69 543 559 I-chronic_disease
syndrome 70 78 560 568 I-chronic_disease
( 79 80 569 570 I-chronic_disease
AIDS)-related 80 93 570 583 I-chronic_disease
illness 94 101 584 591 O

Other 0 5 592 597 O
severe 6 12 598 604 O
acute 13 18 605 610 O
or 19 21 611 613 O
chronic 22 29 614 621 O
medical 30 37 622 629 B-chronic_disease
or 38 40 630 632 O
psychiatric 41 52 633 644 B-chronic_disease
conditions 53 63 645 655 I-chronic_disease
, 63 64 655 656 O
or 65 67 657 659 O
laboratory 68 78 660 670 O
abnormality 79 90 671 682 O
that 91 95 683 687 O
may 96 99 688 691 O
increase 100 108 692 700 O
the 109 112 701 704 O
risk 113 117 705 709 O
associated 118 128 710 720 O
with 129 133 721 725 O
study 134 139 726 731 O
participation 140 153 732 745 O
or 154 156 746 748 O
study 157 162 749 754 B-treatment
drug 163 167 755 759 I-treatment
administration 168 182 760 774 O
, 182 183 774 775 O
or 184 186 776 778 O
may 187 190 779 782 O
interfere 191 200 783 792 O
with 201 205 793 797 O
the 206 209 798 801 O
interpretation 210 224 802 816 O
of 225 227 817 819 O
study 228 233 820 825 O
results 234 241 826 833 O
, 241 242 833 834 O
and 243 246 835 838 O
in 247 249 839 841 O
the 250 253 842 845 O
judgment 254 262 846 854 O
of 263 265 855 857 O
the 266 269 858 861 O
investigator 270 282 862 874 O
would 283 288 875 880 O
make 289 293 881 885 O
the 294 297 886 889 O
patient 298 305 890 897 O
inappropriate 306 319 898 911 O
for 320 323 912 915 O
entry 324 329 916 921 O
into 330 334 922 926 O
this 335 339 927 931 O
study 340 345 932 937 O

Patients 0 8 938 946 O
may 9 12 947 950 O
have 13 17 951 955 O
treated 18 25 956 963 O
and 26 29 964 967 O
stable 30 36 968 974 O
brain 37 42 975 980 B-cancer
metastases 43 53 981 991 I-cancer
; 53 54 991 992 O
they 55 59 993 997 O
must 60 64 998 1002 O
be 65 67 1003 1005 O
off 68 71 1006 1009 O
steroids 72 80 1010 1018 B-treatment
and 81 84 1019 1022 O
must 85 89 1023 1027 O
have 90 94 1028 1032 O
had 95 98 1033 1036 O
stable 99 105 1037 1043 O
brain 106 111 1044 1049 O
metastases 112 122 1050 1060 O
for 123 126 1061 1064 O
at 127 129 1065 1067 O
least 130 135 1068 1073 O
6 136 137 1074 1075 B-lower_bound
months 138 144 1076 1082 I-lower_bound

Patients 0 8 1083 1091 O
must 9 13 1092 1096 O
have 14 18 1097 1101 O
a 19 20 1102 1103 O
life 21 25 1104 1108 B-clinical_variable
expectancy 26 36 1109 1119 I-clinical_variable
of 37 39 1120 1122 O
> 40 41 1123 1124 O
3 42 43 1125 1126 B-lower_bound
months 44 50 1127 1133 I-lower_bound

Patients 0 8 1134 1142 O
must 9 13 1143 1147 O
have 14 18 1148 1152 O
a 19 20 1153 1154 O
negative 21 29 1155 1163 B-pregnancy
pregnancy 30 39 1164 1173 I-pregnancy
test 40 44 1174 1178 O
by 45 47 1179 1181 O
urinalysis 48 58 1182 1192 O

Patients 0 8 1193 1201 O
must 9 13 1202 1206 O
have 14 18 1207 1211 O
evidence 19 27 1212 1220 O
of 28 30 1221 1223 O
metastatic 31 41 1224 1234 B-cancer
disease 42 49 1235 1242 I-cancer
measurable 50 60 1243 1253 O
by 61 63 1254 1256 O
Response 64 72 1257 1265 O
Evaluation 73 83 1266 1276 O
Criteria 84 92 1277 1285 O
in 93 95 1286 1288 O
Solid 96 101 1289 1294 O
Tumors 102 108 1295 1301 O
( 109 110 1302 1303 O
RECIST 110 116 1303 1309 O
) 116 117 1309 1310 O
criteria 118 126 1311 1319 O
or 127 129 1320 1322 O
non 130 133 1323 1326 O
- 133 134 1326 1327 O
measurable 134 144 1327 1337 O
lytic 145 150 1338 1343 O
or 151 153 1344 1346 O
mixed 154 159 1347 1352 O
( 160 161 1353 1354 O
lytic 161 166 1354 1359 O
+ 167 168 1360 1361 O
blastic 169 176 1362 1369 O
) 176 177 1369 1370 O
bone 178 182 1371 1375 O
lesions 183 190 1376 1383 O
in 191 193 1384 1386 O
the 194 197 1387 1390 O
absence 198 205 1391 1398 O
of 206 208 1399 1401 O
measurable 209 219 1402 1412 O
disease 220 227 1413 1420 O

Platelets 0 9 1421 1430 B-clinical_variable
> 10 11 1431 1432 O
100 12 15 1433 1436 B-lower_bound
x 16 17 1437 1438 I-lower_bound
10 18 20 1439 1441 I-lower_bound
^ 20 21 1441 1442 I-lower_bound
9 21 22 1442 1443 I-lower_bound
/ 22 23 1443 1444 I-lower_bound
L 23 24 1444 1445 I-lower_bound

Pregnancy 0 9 1446 1455 B-pregnancy

Presence 0 8 1456 1464 O
of 9 11 1465 1467 O
bleeding 12 20 1468 1476 B-chronic_disease
diathesis 21 30 1477 1486 I-chronic_disease

Prior 0 5 1487 1492 B-treatment
GEM 6 9 1493 1496 I-treatment
therapy 10 17 1497 1504 I-treatment
is 18 20 1505 1507 O
acceptable 21 31 1508 1518 O
as 32 34 1519 1521 O
long 35 39 1522 1526 O
as 40 42 1527 1529 O
the 43 46 1530 1533 O
last 47 51 1534 1538 O
dose 52 56 1539 1543 O
was 57 60 1544 1547 O
≥ 61 62 1548 1549 O
3 63 64 1550 1551 B-lower_bound
months 65 71 1552 1558 I-lower_bound
from 72 76 1559 1563 O
registration 77 89 1564 1576 O
on 90 92 1577 1579 O
this 93 97 1580 1584 O
study 98 103 1585 1590 O

Serum 0 5 1591 1596 B-clinical_variable
calcium 6 13 1597 1604 I-clinical_variable
≤ 14 15 1605 1606 O
12 16 18 1607 1609 B-upper_bound
mg 19 21 1610 1612 I-upper_bound
/ 21 22 1612 1613 I-upper_bound
dl 22 24 1613 1615 I-upper_bound

There 0 5 1616 1621 O
is 6 8 1622 1624 O
no 9 11 1625 1627 O
limit 12 17 1628 1633 O
to 18 20 1634 1636 O
the 21 24 1637 1640 O
number 25 31 1641 1647 O
of 32 34 1648 1650 O
prior 35 40 1651 1656 B-treatment
systemic 41 49 1657 1665 I-treatment
treatment 50 59 1666 1675 I-treatment
regimens 60 68 1676 1684 I-treatment

Use 0 3 1685 1688 O
of 4 6 1689 1691 O
an 7 9 1692 1694 O
effective 10 19 1695 1704 O
means 20 25 1705 1710 O
of 26 28 1711 1713 O
contraception 29 42 1714 1727 O
( 43 44 1728 1729 O
men 44 47 1729 1732 B-gender
and 48 51 1733 1736 O
women 52 57 1737 1742 B-gender
) 57 58 1742 1743 O
is 59 61 1744 1746 O
mandated 62 70 1747 1755 O
in 71 73 1756 1758 O
subjects 74 82 1759 1767 O
of 83 85 1768 1770 O
child 86 91 1771 1776 O
- 91 92 1776 1777 O
bearing 92 99 1777 1784 O
potential 100 109 1785 1794 O

White 0 5 1795 1800 B-clinical_variable
blood 6 11 1801 1806 I-clinical_variable
cell 12 16 1807 1811 I-clinical_variable
( 17 18 1812 1813 I-clinical_variable
WBC 18 21 1813 1816 I-clinical_variable
) 21 22 1816 1817 I-clinical_variable
> 23 24 1818 1819 O
3.0 25 28 1820 1823 B-lower_bound
x 29 30 1824 1825 I-lower_bound
10 31 33 1826 1828 I-lower_bound
^ 33 34 1828 1829 I-lower_bound
9 34 35 1829 1830 I-lower_bound
/ 35 36 1830 1831 I-lower_bound
L 36 37 1831 1832 I-lower_bound

all 0 3 1833 1836 O
female 4 10 1837 1843 B-gender
patients 11 19 1844 1852 I-gender
with 20 24 1853 1857 O
reproductive 25 37 1858 1870 O
potential 38 47 1871 1880 O
must 48 52 1881 1885 O
have 53 57 1886 1890 O
a 58 59 1891 1892 O
negative 60 68 1893 1901 B-pregnancy
pregnancy 69 78 1902 1911 I-pregnancy
test 79 83 1912 1916 O
( 84 85 1917 1918 O
serum 85 90 1918 1923 O
or 91 93 1924 1926 O
urine 94 99 1927 1932 O
) 99 100 1932 1933 O
prior 101 106 1934 1939 O
to 107 109 1940 1942 O
enrollment 110 120 1943 1953 O

female 0 6 1954 1960 B-gender
patients 7 15 1961 1969 I-gender
must 16 20 1970 1974 O
be 21 23 1975 1977 O
surgically 24 34 1978 1988 O
sterile 35 42 1989 1996 O
or 43 45 1997 1999 O
be 46 48 2000 2002 O
post 49 53 2003 2007 O
- 53 54 2007 2008 O
menopausal 54 64 2008 2018 O
, 64 65 2018 2019 O
or 66 68 2020 2022 O
must 69 73 2023 2027 O
agree 74 79 2028 2033 B-contraception_consent
to 80 82 2034 2036 I-contraception_consent
use 83 86 2037 2040 I-contraception_consent
effective 87 96 2041 2050 I-contraception_consent
contraception 97 110 2051 2064 I-contraception_consent
during 111 117 2065 2071 O
the 118 121 2072 2075 O
period 122 128 2076 2082 O
of 129 131 2083 2085 O
therapy 132 139 2086 2093 B-treatment

female 0 6 2094 2100 B-gender
subjects 7 15 2101 2109 I-gender
will 16 20 2110 2114 O
be 21 23 2115 2117 O
advised 24 31 2118 2125 O
that 32 36 2126 2130 O
they 37 41 2131 2135 O
not 42 45 2136 2139 B-pregnancy
become 46 52 2140 2146 I-pregnancy
pregnant 53 61 2147 2155 I-pregnancy
for 62 65 2156 2159 O
at 66 68 2160 2162 O
least 69 74 2163 2168 O
one 75 78 2169 2172 B-lower_bound
month 79 84 2173 2178 I-lower_bound
after 85 90 2179 2184 I-lower_bound
completing 91 101 2185 2195 O
participation 102 115 2196 2209 O
in 116 118 2210 2212 O
the 119 122 2213 2216 O
study 123 128 2217 2222 O

for 0 3 2223 2226 O
subjects 4 12 2227 2235 O
who 13 16 2236 2239 O
are 17 20 2240 2243 O
receiving 21 30 2244 2253 O
warfarin 31 39 2254 2262 B-treatment
for 40 43 2263 2266 O
prophylaxis 44 55 2267 2278 O
or 56 58 2279 2281 O
treatment 59 68 2282 2291 B-treatment
of 69 71 2292 2294 O
thrombosis 72 82 2295 2305 B-chronic_disease
, 82 83 2305 2306 O
INR 84 87 2307 2310 O
values 88 94 2311 2317 O
should 95 101 2318 2324 O
be 102 104 2325 2327 O
carefully 105 114 2328 2337 O
monitored 115 124 2338 2347 O
while 125 130 2348 2353 O
patients 131 139 2354 2362 O
are 140 143 2363 2366 O
on 144 146 2367 2369 O
study 147 152 2370 2375 O

male 0 4 2376 2380 B-gender
patients 5 13 2381 2389 I-gender
must 14 18 2390 2394 O
be 19 21 2395 2397 O
surgically 22 32 2398 2408 B-contraception_consent
sterile 33 40 2409 2416 I-contraception_consent
or 41 43 2417 2419 I-contraception_consent
must 44 48 2420 2424 I-contraception_consent
agree 49 54 2425 2430 I-contraception_consent
to 55 57 2431 2433 I-contraception_consent
use 58 61 2434 2437 I-contraception_consent
effective 62 71 2438 2447 I-contraception_consent
contraception 72 85 2448 2461 I-contraception_consent
during 86 92 2462 2468 O
the 93 96 2469 2472 O
period 97 103 2473 2479 O
of 104 106 2480 2482 O
therapy 107 114 2483 2490 B-treatment
; 114 115 2490 2491 O
the 116 119 2492 2495 O
definition 120 130 2496 2506 O
of 131 133 2507 2509 O
effective 134 143 2510 2519 O
contraception 144 157 2520 2533 O
will 158 162 2534 2538 O
be 163 165 2539 2541 O
based 166 171 2542 2547 O
on 172 174 2548 2550 O
the 175 178 2551 2554 O
judgment 179 187 2555 2563 O
of 188 190 2564 2566 O
the 191 194 2567 2570 O
principal 195 204 2571 2580 O
investigator 205 217 2581 2593 O
or 218 220 2594 2596 O
a 221 222 2597 2598 O
designated 223 233 2599 2609 O
associate 234 243 2610 2619 O

